Cardium Therapeutics, Inc. (CXM) Swings to Q4 Loss

March 30, 2012 9:16 AM

Cardium Therapeutics, Inc. (AMEX: CXM) reported Q4 EPS of ($0.02), versus $0.01 reported last year.

For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.

No results found